BAJAJ BROKING

Notification
No new Notification messages
Inventurus Knowledge Solutions IPO is Open!
Apply for the Inventurus Knowledge Solutions IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
norris medicines ltd. stock

NORRIS MEDICINES LTD. Share Price

20.8 -0.42 (-1.97%)
Dec 13 2024 03:15 PM Pharmaceuticals NSE: NORRIS

NORRIS MEDICINES LTD. Share Price Update

As of the latest trading session, NORRIS MEDICINES LTD. share price is currently at 20.8, which is down by -0.42 from its previous closing. Today, the stock has fluctuated between 20.80 and 20.80. Over the past year, NORRIS MEDICINES LTD. has achieved a return of 76.53 %. In the last month alone, the return has been -15.69 %. Read More...

NORRIS MEDICINES LTD. Performance

Day Range

Low20.80 High20.80
20.80

52 Week Range

Low 10.70 High 27.74
20.80

NORRIS MEDICINES LTD. Share Price

524414

NORRIS

img img img img
No Data Available

Open Price

20.80

Prev. Close

21.22

Volume (Shares)

175.00

Total traded value

.03

Upper Circuit

21.64

Lower Circuit

20.80

Note: The current prices & values are delayed, Login to your account for live updates.

NORRIS MEDICINES LTD. Fundamentals


(Standalone)

Market Cap (Cr) 20.80
PE Ratio (TTM) -25.37
Book Value / Share -14.28
Beta 0.06
ROE 0.00%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) -0.36

NORRIS MEDICINES LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 1.27
Operating Expense 1.63
Net Profit -0.36
Net Profit Margin (%) -28.34
Earnings Per Share (EPS) -0.36
EBITDA -0.14
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 0.72
Operating Expense 1.10
Net Profit -0.37
Net Profit Margin (%) -51.38
Earnings Per Share (EPS) -0.37
EBITDA -0.15
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 1.49
Operating Expense 1.25
Net Profit 0.17
Net Profit Margin (%) 11.40
Earnings Per Share (EPS) 0.17
EBITDA 0.51
Effective Tax Rate (%) 34.61
Particulars DEC 2023 (Values in Cr)
Revenue 0.65
Operating Expense 0.91
Net Profit -0.27
Net Profit Margin (%) -41.53
Earnings Per Share (EPS) -0.27
EBITDA -0.04
Effective Tax Rate (%) 0.00
Particulars SEP 2023 (Values in Cr)
Revenue 2.56
Operating Expense 3.04
Net Profit -0.48
Net Profit Margin (%) -18.75
Earnings Per Share (EPS) -0.48
EBITDA -0.25
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 5.64
Operating Expense 6.76
Net Profit -1.19
Net Profit Margin (%) -21.09
Earnings Per Share (EPS) -1.19
EBITDA -0.16
Effective Tax Rate (%) -8.18
Particulars MAR 2023 (Values in Cr)
Revenue 8.36
Operating Expense 9.57
Net Profit -1.75
Net Profit Margin (%) -20.93
Earnings Per Share (EPS) -1.75
EBITDA 0.94
Effective Tax Rate (%) -47.05
Particulars MAR 2022 (Values in Cr)
Revenue 9.44
Operating Expense 11.65
Net Profit -3.26
Net Profit Margin (%) -34.53
Earnings Per Share (EPS) -3.26
EBITDA -0.04
Effective Tax Rate (%) -49.54
Particulars MAR 2021 (Values in Cr)
Revenue 12.25
Operating Expense 16.29
Net Profit -4.96
Net Profit Margin (%) -40.48
Earnings Per Share (EPS) -4.96
EBITDA -1.69
Effective Tax Rate (%) -24.31
Particulars MAR 2020 (Values in Cr)
Revenue 7.84
Operating Expense 11.61
Net Profit -2.84
Net Profit Margin (%) -36.22
Earnings Per Share (EPS) -2.84
EBITDA -2.07
Effective Tax Rate (%) 22.82
Particulars MAR 2024 (Values in Cr)
Book Value / Share -13.73
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -2.84
Particulars MAR 2023 (Values in Cr)
Book Value / Share -12.54
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 11.24
Particulars MAR 2022 (Values in Cr)
Book Value / Share -10.77
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -0.53
Particulars MAR 2021 (Values in Cr)
Book Value / Share -7.49
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -13.88
Particulars MAR 2020 (Values in Cr)
Book Value / Share -2.49
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -26.20
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.03
Total Assets 14.18
Total Liabilities 14.18
Total Equity -13.63
Share Outstanding 10000700
Price to Book Ratio -0.99
Return on Assets (%) -8.36
Return on Capital (%) -15.03
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 13.68
Total Liabilities 13.68
Total Equity -12.44
Share Outstanding 9925750
Price to Book Ratio -0.83
Return on Assets (%) -12.78
Return on Capital (%) -19.52
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 14.19
Total Liabilities 14.19
Total Equity -10.69
Share Outstanding 9925750
Price to Book Ratio 0.00
Return on Assets (%) -22.99
Return on Capital (%) -31.43
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 19.78
Total Liabilities 19.78
Total Equity -7.43
Share Outstanding 9925750
Price to Book Ratio -0.87
Return on Assets (%) -25.07
Return on Capital (%) -61.31
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.06
Total Assets 20.55
Total Liabilities 20.55
Total Equity -2.46
Share Outstanding 9925750
Price to Book Ratio -1.13
Return on Assets (%) -13.82
Return on Capital (%) -22.7
Particulars MAR 2024 (Values in Cr)
Net Income -1.18
Cash from Operations 0.16
Cash from Investing 0.05
Cash from Financing -0.20
Net change in Cash 0.01
Free Cash Flow 0.17
Particulars MAR 2023 (Values in Cr)
Net Income -1.74
Cash from Operations 1.19
Cash from Investing -0.02
Cash from Financing -1.17
Net change in Cash 0.00
Free Cash Flow 1.22
Particulars MAR 2022 (Values in Cr)
Net Income -3.26
Cash from Operations -1.00
Cash from Investing -0.08
Cash from Financing 1.09
Net change in Cash 0.00
Free Cash Flow -0.95
Particulars MAR 2021 (Values in Cr)
Net Income -4.96
Cash from Operations 1.11
Cash from Investing -0.06
Cash from Financing -1.09
Net change in Cash -0.04
Free Cash Flow 1.20
Particulars MAR 2020 (Values in Cr)
Net Income -2.84
Cash from Operations -2.88
Cash from Investing 0.00
Cash from Financing 2.85
Net change in Cash -0.01
Free Cash Flow -2.80
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.57 37.68 3.57 502.48 37.54 / 77.70
BLISS GVS PHARMA LTD 173.80 21.75 1.81 1830.67 92.25 / 175.80
CIPLA LTD 1446.35 25.30 4.11 116809.04 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 406.80 141.25 4.12 1197.25 145.00 / 440.00
GLAXOSMITHKLINE PHARMA LT 2306.65 48.74 23.36 39076.04 1668.20 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.57 57.02 11.14 502.48 37.54 / 77.70
AMRUTAJAN HEALTH LTD 751.60 45.72 7.29 2172.92 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6636.00 128.88 24.42 16590.00 4050.15 / 8139.85
BLISS GVS PHARMA LTD 173.80 22.66 1.78 1830.67 92.25 / 175.80

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 22.00
  • 26 Days 21.30
  • 10 Days 21.50
  • 50 Days 20.50
  • 12 Days 21.30
  • 100 Days 18.40
  • 20 Days 22.10
  • 200 Days 22.10
21.22
PIVOT
First Resistance 21.22
Second Resistance 21.22
Third Resistance 21.22
First Support 21.22
Second Support 21.22
Third Support 21.22
RSI 50.66
MACD -0.02
Commodity Channel Index (CCI) -19.02
ADX 20.67
Williams % R -34.58

Over 1 Month

down

-15.69

Over 3 Months

down

11.86

Over 6 Months

down

87.78

Over 1 Year

down

76.53

Over 3 Years

down

23.59

Over 5 Years

down

41.20

NORRIS MEDICINES LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

NORRIS MEDICINES LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
65.91
Promoter Holdings
34.01
FII
0.0
DII
0.06
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Fab Metals Private Limited Public Shareholding 4199259.0 41.99
Vimal D Shah Shareholding of Promoter and Promoter Group 2360441.0 23.6
Navsarjan Investment & Trading Pvt Ltd Shareholding of Promoter and Promoter Group 1000000.0 10.0
Lkp Securities Limited Public Shareholding 150000.0 1.5
Dhirendra Kantilal Shah Huf Shareholding of Promoter and Promoter Group 34350.0 0.34
Navnit Jethabhai Patel Shareholding of Promoter and Promoter Group 3840.0 0.04
Nimish Bhishma Thakore Shareholding of Promoter and Promoter Group 1440.0 0.01
Milind L Upadhyaya Shareholding of Promoter and Promoter Group 1500.0 0.01

NORRIS MEDICINES LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About NORRIS MEDICINES LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by NORRIS MEDICINES LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Norris Medicines Ltd?

Answer Field

The share price of Norris Medicines Ltd for NSE is ₹ 0.00 and for BSE is ₹ 20.80.

What is the Market Cap of Norris Medicines Ltd?

Answer Field

The market cap of Norris Medicines Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 20.80 Cr. as of now.

What is the 52 Week High and Low of Norris Medicines Ltd?

Answer Field

The 52 Week High and Low of Norris Medicines Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 27.74 and ₹ 10.70.

How to Buy Norris Medicines Ltd share?

Answer Field

You can trade in Norris Medicines Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Norris Medicines Ltd?

Answer Field

The 1 year returns on the stock has been 76.53%.

What is the Current Share Price of Norris Medicines Ltd?

Answer Field

Norris Medicines Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 20.80 as on Dec 13 2024 03:15 PM.

What is the Market Cap of Norris Medicines Ltd Share?

Answer Field

The market cap of Norris Medicines Ltd for NSE ₹ 0.0 & for BSE ₹ 20.80 as on Dec 13 2024 03:15 PM.

What is the P/E Ratio of Norris Medicines Ltd Share?

Answer Field

As on Dec 13 2024 03:15 PM the price-to-earnings (PE) ratio for Norris Medicines Ltd share is -25.37.

What is the PB ratio of Norris Medicines Ltd Share?

Answer Field

As on Dec 13 2024 03:15 PM, the price-to-book (PB) ratio for Norris Medicines Ltd share is -14.28.

How to Buy Norris Medicines Ltd Share?

Answer Field

You can trade in Norris Medicines Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Norris Medicines Ltd Share on Bajaj Broking App?

Answer Field

To buy Norris Medicines Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Norris Medicines Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader